GPBAR1 and metabolic dysfunction-associated steatotic liver disease: Although SCFA directly or via binding to G-protein-coupled receptors (GPCR) appear to promote NAFLD, other effects of SCFA might be beneficial for NAFLD mostly by modulating AMPK activity in the liver [236].